Sign in

CIK 0001472012 · Non-accelerated filer

Immunome Inc.

Sign in to watch
Ticker
IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770694340
Phone
610-321-3700
Business address
18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$334,224
in 1 filing, $334K under 10b5-1 plans

Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Higgins Jack −$334K Chief Scientific Officer sold 17% of stake

Reading 56 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-02 Rosett Max Chief Financial Officer Option exercise 10b5-1 +31,848 $1.05 $33K 79,324
2026-04-02 Rosett Max Chief Financial Officer Option exercise 10b5-1 +39,713 $1.35 $54K 119,037
2026-04-02 Rosett Max Chief Financial Officer Sale 10b5-1 −63,656 $21.91 $1.4M 55,381
2026-04-02 Rosett Max Chief Financial Officer Sale 10b5-1 −1,344 $22.48 $30K 54,037
2026-04-02 Rosett Max Chief Financial Officer Option exercise · Stock option (right to buy) 10b5-1 −31,848 60,000
2026-04-02 Rosett Max Chief Financial Officer Option exercise · Stock option (right to buy) 10b5-1 −39,713 0
2026-04-02 Higgins Jack Chief Scientific Officer Sale 10b5-1 −9,438 $21.64 $204K 22,000
2026-03-30 Higgins Jack Chief Scientific Officer Gift −6,291 31,438
2026-03-27 SIEGALL CLAY B President and CEO Purchase +25,450 $19.67 $501K 690,704
2026-03-23 WAGENHEIM PHILIP Director Sale −28,200 $20.65 $582K 341,147
2026-03-20 WAGENHEIM PHILIP Director Sale −36,800 $20.47 $753K 369,347
2026-03-11 BIENAIME JEAN JACQUES Director Purchase +1,000 $21.55 $22K 38,415
2026-03-10 BIENAIME JEAN JACQUES Director Purchase +1,000 $22.12 $22K 37,415
2025-12-30 SIEGALL CLAY B President and CEO Purchase +4,729 $21.15 $100K 665,254
2025-12-22 Barchas Isaac Director Sale 10b5-1 −371,949 $21.72 $8.1M 2,042,432
2025-12-22 Barchas Isaac Director Sale 10b5-1 −11,251 $22.34 $251K 2,031,181
2025-12-19 Tsai Philip Chief Technical Officer Purchase +10,000 $20.49 $205K 43,300
2025-12-19 Higgins Jack Chief Scientific Officer Gift −1,000 39,729
2025-12-19 Higgins Jack Chief Scientific Officer Gift +1,000 1,000
2025-12-19 Higgins Jack Chief Scientific Officer Gift −1,000 38,729

Page 4 of 8 · 159 trades